Connect with us

Technology

Gene Solutions Advances Precision Oncology Education in Malaysia with the ”Beyond Actionable” Academy

Published

2 weeks ago

on

At the Precision Oncology Academy 2026, leading international experts explored how insights from tumour DNA and RNA can reveal treatment opportunities, explain drug resistance, and translate into more confident treatment decisions to improve cancer care.

KUALA LUMPUR, Malaysia, Aug. 4, 2026 /PRNewswire/ — Gene Solutions Malaysia hosted the Precision Oncology Academy 2026 on 25 July 2026 at the Sheraton Petaling Jaya Hotel under the theme ”Beyond Actionable”. An extension of the international K-CONNECT Platform and the recent K-CONNECT Summit 2026 in Vietnam, the Academy brought together oncology experts from the United Arab Emirates, Singapore, Malaysia, US and Vietnam. Through scientific lectures, multidisciplinary case discussions and interactive workshops, the programme addressed a central question: How can a deeper understanding of each patient’s cancer lead to more informed treatment decisions?

The Academy’s expert faculty was led by Chairperson Prof. Dr. Ho Gwo Fuang of Curie Oncology, Malaysia, and Co-chairperson Prof. Dr. Darren Lim Wan-Teck of the National Cancer Centre Singapore. They were joined by Prof. Dr. Shaheenah Dawood of Mediclinic Middle East, UAE; Dr. Christina Lai Nye Bing of Hospital Picaso, Malaysia; Dr. Katherine Teh Hooi Lay of Gleneagles Hospital Johor, Malaysia; Dr. Jenson Sow Wen Jen of Curie Oncology, Malaysia; Dr. Sinh Nguyen Duy and Dr. Lan Tu Ngoc Ly of Gene Solutions. Together, the faculty brought expertise spanning clinical oncology, cancer genomics, molecular diagnostics and genomic data interpretation, creating a multidisciplinary forum for translating complex molecular insights into practical clinical decisions.

Decoding the molecular story of cancer

Cancer is not defined solely by its site of origin in the body. Every tumour carries a complex molecular story, written in changes across its DNA and RNA. These changes influence how cancer develops, how it responds to treatment and how it may become resistant over time.

The Academy examined how large genomic and transcriptomic panels comprehensive profiling can provide a broader view of tumour biology. This includes comprehensive multi-omic approaches such as K-4CARE, which combines tissue-based DNA and RNA profiling with liquid biopsy circulating tumour DNA (ctDNA) analysis for both molecular profiling and ongoing monitoring. DNA profiling may identify genomic alterations associated with cancer growth and reveal biomarkers linked to targeted therapies, immunotherapies or clinical trials. RNA analysis can detect clinically important gene fusions and splice variants that may be missed or remain unclear through DNA-only testing.

The discussions highlighted the complementary roles of tissue and liquid (plasma) next-generation sequencing. While tissue testing remains essential for initial diagnosis and detailed characterisation, liquid biopsy can capture a wider view of tumour heterogeneity and resistance, particularly at progression. Used together, the two approaches offer clinicians a more complete molecular picture to guide treatment decisions.

The value of tissue and liquid longitudinal molecular profiling was illustrated by Prof. Dr. Darren Lim, who presented a real-world case of a patient with ALK-positive lung cancer managed over several years with serial next-generation sequencing. The case illustrated how repeated molecular profiling — combining tissue and plasma testing — can reveal a broader resistance landscape and support sequential treatment decisions throughout a patient’s journey.

Together, DNA, RNA, and ctDNA insights can provide clinicians with a more comprehensive understanding of the tumour. Molecular testing does not guarantee an actionable finding or suitable treatment, but it may uncover important information that would otherwise remain unseen.

Following cancer as it evolves

The Academy also highlighted the growing role of liquid biopsy in providing a more dynamic and holistic view of cancer.

One of the Academy’s key international speakers, Prof. Dr. Shaheenah Dawood, shared clinical perspectives on the evolving role of minimal residual disease (MRD) and ctDNA monitoring across cancer types. Prof. Dr. Dawood also reviewed the latest ASCO and NCCN guideline updates on liquid biopsy.

While tissue biopsy examines tumour material obtained from a particular location at a particular point in time, liquid biopsy detects cancer-related signals, including ctDNA, in the blood and can be repeated with a single blood draw. Depending on the clinical context and available evidence, liquid biopsy may help clinicians monitor treatment response, investigate emerging resistance or detect molecular signs of MRD. Because it can be performed repeatedly over time, liquid biopsy also offers the potential to follow how a cancer changes throughout treatment.

“The future of cancer management is dynamic. Liquid biopsy enables continuous monitoring of tumour evolution, helping clinicians make earlier, more informed treatment decisions.” said Prof. Shaheenah Dawood.

From complex data to confident decisions

The speakers emphasized that precision oncology is not simply about testing more genes or generating more data. The real challenge is determining which findings are clinically meaningful for an individual patient.

Not every molecular alteration drives cancer, and not every detected alteration can guide treatment. When a potentially actionable biomarker is identified, clinicians must consider the strength of the supporting evidence, the cancer type, previous treatments, the patient’s overall condition, and the availability of appropriate therapies or clinical trials.

This is why genomic findings must be interpreted together with pathology, medical history, and multidisciplinary clinical expertise.

“Precision oncology is no longer just about generating genomic data. It is about translating genomic insights, including MRD and ctDNA, into confident clinical decisions that improve patient care.” said Prof. Ho Gwo Fuang who chaired the Academy.

Connecting regional knowledge with clinical practice

The Precision Oncology Academy followed the K-CONNECT Summit 2026 | AI & Multi-omics – Shifting Paradigms in the New Era of Early Cancer Detection and Precision Oncology, recently held in Vietnam.

K-CONNECT was established by Gene Solutions as an international platform for multidisciplinary exchange in cancer genomics, ctDNA, molecular residual disease monitoring, comprehensive genomic and transcriptomic profiling, artificial intelligence and precision medicine.

“The K-CONNECT Platform was created to foster collaboration across the region, while Precision Oncology Academy translates that collaboration into practical clinical learning. By bringing together leading experts and real-world evidence, we hope to empower clinicians to confidently integrate precision oncology into routine patient care.” said Lim Chiun Khee, Country Director, Gene Solutions Malaysia.

For patients and families, cancer genomics may appear complex, but its purpose is clear: to understand the disease more completely so that treatment decisions can become more precise.

Through the K-CONNECT Platform, K-CONNECT Summit and Precision Oncology Academy, Gene Solutions continues to connect scientific advancement with clinical practice, helping make the evolving possibilities of precision oncology more accessible to clinicians and, ultimately, more meaningful for patients.

About Gene Solutions

Gene Solutions is a global biotechnology company headquartered in Singapore with a mission to make advanced genomic solutions accessible and affordable. Leveraging next-generation sequencing, multi-omics and artificial intelligence, the company offers a portfolio of solutions across multi-cancer detection, precision oncology and reproductive health, including SPOT-MAS, K-TRACK and K-4CARE.

Gene Solutions operates CAP-accredited NGS laboratories and has delivered millions of genetic tests worldwide since 2017. For more information, visit www.genesolutions.com and follow Gene Solutions on LinkedIn, Facebook, and X (Twitter).

For inquiries, please contact pr@genesolutions.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/gene-solutions-advances-precision-oncology-education-in-malaysia-with-the-beyond-actionable-academy-302841040.html

SOURCE Gene Solutions; GENE SOLUTIONS SGP PTE. LTD.

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Brook Gaming Officially Launches Sniper 2 Flagship Keyboard and Mouse Converter for Cross-Platform Console Gaming

Published

20 minutes ago

on

August 15, 2026

By

NEW TAIPEI CITY, Aug. 15, 2026 /PRNewswire/ — Brook Gaming, the leading Taiwanese gaming accessory brand, has officially announced the global launch of the “Sniper 2” flagship keyboard and mouse converter. Designed to bridge the gap between PC peripherals and gaming consoles, the Sniper 2 allows players to enjoy their favorite console games using familiar keyboard and mouse configurations.

Plug-and-Play Across Major Platforms 
The Sniper 2 delivers smooth and precise control across a wide range of platforms. It offers comprehensive support for PS5, PS4, Xbox Series X|S, Xbox One, Nintendo Switch, PC, mobile devices (iOS/Android), and the highly anticipated Nintendo Switch 2 (NS2). Compatible with major wired and 2.4 GHz wireless keyboards and mice from top brands like Razer, Logitech, ZOWIE, and ROG, the device features true plug-and-play functionality. Whether playing action RPGs, racing titles, or shooters, players can experience seamless control in any genre.

Personalized Control Center with Full-Color Display and Dedicated App
The Sniper 2 features a compact design equipped with a Full-Color Status Display to instantly show current system configurations, alongside customizable dynamic RGB ambient lighting.

To provide an optimized experience, the dedicated Brook Sniper 2 App (available for iOS and Android) serves as a personal control center. Users can easily customize DPI, X/Y axis sensitivity, remap controller buttons, configure macros, and adjust stick deadzones to combat drift. Additionally, players can download official Config profiles or share their own settings with the gaming community.

With over two decades of experience in hardware development, Brook Gaming remains committed to its “Your Game, Our Play” philosophy. The Sniper 2 represents a continuous breakthrough in cross-platform compatibility, offering players total freedom in how they play.

For More Information

Sniper 2 Official Page: 
https://www.brookaccessory.com/products/sniper2/index.htmlBrook Gaming Official Website: 
https://www.brookaccessory.com/

About Brook Gaming
With over 20 years of experience in gaming hardware design and manufacturing, Brook Gaming believes that gaming should not be limited by equipment. We are committed to breaking down platform barriers through innovative technology, fulfilling our brand promise: “Your Game, Our Play.” We will continue to stand at the forefront of player needs, redefining the infinite possibilities of cross-platform gaming with forward-looking products.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/brook-gaming-officially-launches-sniper-2-flagship-keyboard-and-mouse-converter-for-cross-platform-console-gaming-302823347.html

Continue Reading

Technology

Levels® Launches Strawberry and Unflavored Whey Protein Powders at Select Walmart Stores Nationwide

Published

20 minutes ago

on

August 15, 2026

By

The minimal-ingredient whey protein powders are now available in 1.48 lb canisters at select Walmart locations nationwide, along with single-serve sachets in Vanilla Bean and Double Chocolate.

JUPITER, Fla., Aug. 15, 2026 /PRNewswire/ — Today, Levels announced the launch of 1.48 lb canisters of Strawberry and Unflavored Whey Protein Powders, along with single-serve offerings in two of its most popular whey protein flavors, Vanilla Bean and Double Chocolate.

Levels® Launches Strawberry and Unflavored Whey Protein Powders at Select Walmart Stores Nationwide

These four products join Vanilla Bean and Double Chocolate 1.48 lb canisters already at Walmart stores across the U.S. The expanded flavor offerings broaden Walmart shoppers’ access to Levels’ whey protein, giving consumers new flavor and size options.

The Unflavored Whey Protein Powder boasts 25g of protein and 5.6g of BCAAs per scoop, with only two ingredients total. The Strawberry Whey Protein Powder contains 24g of protein and 5.4g of BCAAs per scoop, with only eight ingredients.

Both products hold the Clean Label Project® Purity Award. The rigorous testing screens for over 400 potential contaminants, including heavy metals, pesticides, and plasticizers, making it one of the most demanding certifications in the industry and one that’s held by less than 30% of brands in the space.

“Consumers are demanding better protein — products made with real ingredients they can actually trust,” said Blake Niemann, Founder & CEO of Levels. “Launching four flavors and sizes that are new to Walmart makes it easier than ever for people to enjoy high-quality whey protein made with minimal ingredients, transparent sourcing, and nothing artificial.”

“Walmart is a best-in-class retail partner for Levels, and we’re excited to bring new flavors and sizes to Walmart shoppers across the country. This continued expansion increases Levels’ Walmart distribution by nearly 120%, reinforcing the brand’s strong and growing presence at retail.”

In an industry beset by rising concerns about product safety and ingredient sourcing, Levels stands out with its radically simple approach and minimal 6–8 ingredient formulas. Levels sources grass-fed, hormone-free dairy to make its whey protein concentrate, the least-processed form of whey.

In addition to Walmart, Levels can be found at major retailers including Sam’s Club, Costco, Target, Kroger, Meijer, Wegmans, H-E-B, and Amazon. Levels products are also available online at levelsprotein.com and through leading retail websites.

About Levels
Founded by Blake Niemann, Levels was built on a simple belief: protein powder shouldn’t need a chemistry degree to understand. The brand builds its whey powders around high protein content, minimal ingredients, and flavors that are ridiculously good tasting — a formula that has driven distribution to a projected 10,000 retail locations and 30,000 points of distribution in 2026.

About Walmart
Bentonville, Arkansas-based Walmart Inc. (NYSE: WMT) serves customers at more than 10,500 stores and clubs in 19 countries, as well as at Walmart.com, with the purpose of saving people money so they can live better. Since 1962, Walmart has been committed to creating opportunities and bringing value to customers, associates, and communities around the world. Additional company information can be found by visiting the corporate website and press center.

Media Contacts
Deirdre O’Donoghue, Levels: deirdre@levelsprotein.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/levels-launches-strawberry-and-unflavored-whey-protein-powders-at-select-walmart-stores-nationwide-302852224.html

SOURCE Levels®

Continue Reading

Technology

Creality Launches SPARKX i7 Nano: Bringing Compact Multi-Color Printing to $299

Published

1 hour ago

on

August 15, 2026

By

HOUSTON, Aug. 15, 2026 /PRNewswire/ — Creality, a global leader in the 3D printing industry, today announced the availability of the SPARKX i7 Nano, the latest addition to its i7 series. This desktop 3D printer saves space while delivering premium print quality across up to four colors. With a minimalist design that fits easily on a desk, the i7 Nano makes multi-color 3D printing more compact, affordable, and accessible.

Following the January debut of the i7 Color Combo, the i7 Nano is also built for smarter, more effortless 3D printing. It integrates AI-powered capabilities that simplify both creation and printing, including CubeMe for automatically turning 2D portraits into multi-color 3D models. A built-in 720p AI camera monitors prints for common failures such as spaghetti and air printing, while vibration compensation and dynamic pressure adjustment help maintain consistent print quality.

Beyond these shared features, the i7 Nano comes with an integrated spool holder and optimized filament layout, taking up less desktop space and making it easier to fit into compact workspaces. The spool holder mounts directly onto the printer body with a convenient snap-on design, eliminating the need for an external CFS Lite. This compact solution keeps the printer’s footprint small while maintaining a clean appearance without compromising printing performance.

Paired with the new CFS nano Kit, a small unit mounted on top of the printer, the i7 Nano enables vibrant multi-color printing with automatic filament switching for up to four colors. The CFS nano features a dual-motor system, with one motor controlling filament channel switching and the other handling filament feeding and retraction. This ensures smooth and efficient color changes while keeping the overall setup streamlined. The CFS nano also allows quick installation without complex disassembly or modifications and is compatible with existing i7 units.

The i7 Nano features a build volume of 260 × 260 × 255 mm and a maximum printing speed of up to 500 mm/s. It supports a hardened steel nozzle with a maximum temperature of 300°C and multiple nozzle diameters, including 0.2, 0.4, 0.6, and 0.8 mm. It is also equipped with automatic bed leveling, RFID filament reading and automatic filament refill to deliver an easy-to-use and reliable printing experience for beginners.

The SPARKX i7 Nano with CFS nano Kit will be available starting from August 15 for $299 in the U.S. at the Creality US Store.

View original content to download multimedia:https://www.prnewswire.com/news-releases/creality-launches-sparkx-i7-nano-bringing-compact-multi-color-printing-to-299-302851758.html

SOURCE Creality

Continue Reading

Trending